People with dementia have a high risk of drug side effects. However, they are underrepresented in clinical trials, therefore, there is uncertainty about drug effects in this group. We estimated causal effects associated with deprescribing cardiovascular medication in people with dementia using target trial emulation and a cumulative exposure study. We then explored the specificity of our findings using negative control exposure analysis.